Cargando…

Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole

BACKGROUND: Urinary tract infections caused by extended-spectrum beta-lactamase-producing bacteria are increasing worldwide. At our hospital, the number of pediatric patients hospitalized because of an upper urinary tract infection has dramatically increased since 2016. In total, 60.5% of urinary tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horie, Akiyoshi, Nariai, Akiyoshi, Katou, Fumihide, Abe, Yasuhiro, Saito, Yuya, Koike, Daisuke, Hirade, Tomohiro, Ito, Tomoko, Wakuri, Miho, Fukuma, Aiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797641/ https://www.ncbi.nlm.nih.gov/pubmed/31428892 http://dx.doi.org/10.1007/s10157-019-01775-w

Ejemplares similares

Long‐term renal follow up of preterm neonates born before 35 weeks of gestation
por: Horie, Akiyoshi, et al.
Publicado: (2019)

Subcutaneous abscess caused by Streptococcus pneumoniae serotype 28F in an infant: a case report
por: Hirade, Tomohiro, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function
por: Hamada, Yukihiro, et al.
Publicado: (2022)

Laryngeal web with 22q11.2 deletion syndrome
por: Abe, Yasuhiro, et al.
Publicado: (2022)

2778. Retrospective evaluation of effectiveness of Flomoxef for infections due to extended-spectrum β-lactamase-producing Enterobacterales
por: Koizumi, Ryuji, et al.
Publicado: (2023)

Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase–Producing Enterobacterales vs Carbapenems: A Retrospective Study
por: Kashihara, Eriko, et al.
Publicado: (2023)

In vitro efficacy of humanized regimen of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
por: Yamashiro, Hidenori, et al.
Publicado: (2023)

Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia
por: Lee, Chen-Hsiang, et al.
Publicado: (2018)

A multicentre study to determine the in vitro efficacy of flomoxef against extended-spectrum beta-lactamase producing Escherichia coli in Malaysia
por: Yap, Polly Soo Xi, et al.
Publicado: (2023)

Pharmacokinetic–pharmacodynamic analysis of cefmetazole against extended-spectrum β-lactamase-producing Enterobacteriaceae in dogs using Monte Carlo Simulation
por: Kusumoto, Mizuki, et al.
Publicado: (2023)

In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Associated with Urinary Tract Infections in Malaysia
por: Ngoi, Soo Tein, et al.
Publicado: (2021)

A suspicious case of cefmetazole‐induced hypoprothrombinemia
por: Kodama, Nobuhiro, et al.
Publicado: (2017)

Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
por: Darlow, Christopher A, et al.
Publicado: (2021)

The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum
por: Goto, Akihiko, et al.
Publicado: (2021)

Hypoprothrombinemia During Cefmetazole Treatment: A Case Report
por: Haba, Yuichiro, et al.
Publicado: (2022)

Correction to: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
por: Darlow, Christopher A, et al.
Publicado: (2022)

Bactericidal efficacy of meropenem in combination with cefmetazole against IMP-producing carbapenem-resistant Enterobacteriaceae
por: Abe, Ryuichiro, et al.
Publicado: (2019)

Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum
por: Kang, Cheol-In
Publicado: (2021)

Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniae in patients on maintenance hemodialysis
por: Yang, Chih-Chao, et al.
Publicado: (2012)

Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
por: Fukuchi, Takahiko, et al.
Publicado: (2016)

A Case of Alveolar Bleeding from Clotting Abnormality by Cefmetazole
por: Nakano, Eri, et al.
Publicado: (2019)

Errate: Hypoprothrombinemia During Cefmetazole Treatment: A Case Report
por: Haba, Yuichiro, et al.
Publicado: (2022)

Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales—authors’ response
por: Darlow, Christopher A, et al.
Publicado: (2022)

Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
por: Lee, Chen-Hsiang, et al.
Publicado: (2018)

Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains
por: Ito, Ryota, et al.
Publicado: (2022)

Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance
por: Darlow, Christopher A., et al.
Publicado: (2022)

Single-Blind, Prospective, Randomized Study of Cefmetazole and Cefoxitin in the Treatment of Postcesarean Endometritis
por: Chatwani, Ashwin, et al.
Publicado: (1995)

Optimal dosage of cefmetazole for intraoperative antimicrobial prophylaxis in patients undergoing surgery for colorectal cancer
por: Tomizawa, Atsushi, et al.
Publicado: (2017)

Amino Acid Synthesis in a Supercritical Carbon Dioxide - Water System
por: Fujioka, Kouki, et al.
Publicado: (2009)

Non-Cytotoxic Nanomaterials Enhance Antimicrobial Activities of Cefmetazole against Multidrug-Resistant Neisseria gonorrhoeae
por: Li, Lan-Hui, et al.
Publicado: (2013)

Analysis of cases of severe respiratory failure in children with influenza (H1N1) 2009 infection in Japan
por: Uchimura, Toru, et al.
Publicado: (2011)

The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway
por: Luo, Shanjun, et al.
Publicado: (2022)

A Response to Research Article “Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies
por: Satoh, Daisuke, et al.
Publicado: (2017)

Acquired Class D β-Lactamases
por: Antunes, Nuno T., et al.
Publicado: (2014)

Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings
por: Darlow, Christopher A, et al.
Publicado: (2022)

The Genotypic and Phenotypic Characteristics Contributing to Flomoxef Sensitivity in Clinical Isolates of ESBL-Producing E. coli Strains from Urinary Tract Infections
por: Sakaeda, Kazuma, et al.
Publicado: (2023)

Attenuation of prostaglandin E(2 )elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole
por: Akanuma, Shin-ichi, et al.
Publicado: (2011)

Poverty and Community-Acquired Antimicrobial Resistance with Extended-Spectrum β-Lactamase–Producing Organisms, Hyderabad, India
por: Alsan, Marcella, et al.
Publicado: (2018)

Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia
por: Raouf, Faez Erees Abdul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n1bfa14pogrkeknk68nkibvplc